Pharmalot - That’s the latest plan by the agency, which is grappling with a controversy over contaminated batches of the widely used blood thinner. The version sold by Baxter International, you may recall, has been linked to nearly 800 reports of serious adverse events and 19 deaths in recent weeks and the problem has been traced to a plant in China, which the FDA failed to inspect until the scandal broke....